[144] DXP Enterprises Inc SEC Filing

Rhea-AI Filing Summary

DXP Enterprises filed a Form 144 notifying a proposed sale of 5,000 common shares, with an aggregate market value of $589,800. The shares are to be sold through Charles Schwab & Co and listed as to be traded on Nasdaq with an approximate sale date of 08/12/2025. The shares were acquired on 02/01/2023 as restricted stock issuances from the issuer. The filer reports no securities sold in the past three months for the account and represents that they do not possess undisclosed material adverse information about the issuer.

Insights

Financial Analyst

TL;DR: Routine insider notice to sell restricted shares; amount disclosed but not large relative to outstanding shares shown.

The Form 144 documents a proposed sale of 5,000 common shares valued at $589,800. The shares were acquired as restricted stock on 02/01/2023 and are to be sold via Charles Schwab on 08/12/2025. The filing notes no sales in the prior three months, which suggests this is an isolated disposition rather than part of an ongoing selling pattern disclosed here. From a market-impact perspective, the filing provides clear transactional detail but does not by itself change issuer fundamentals.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure consistent with Rule 144 requirements; attestation to lack of undisclosed material information included.

The filer declares the sale under Rule 144 and includes the required attestation that they are not aware of undisclosed material adverse information. The securities were restricted stock issuances acquired on 02/01/2023, and the notice lists broker information and the approximate sale date. The filing shows governance-level compliance with trading disclosure rules but contains no additional governance events or changes.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	Charles Schwab & Co 3000 Schwab Way westlake TX 76262	5000	589800.00	15694084	08/12/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	02/01/2023	restricted stock issuances	issuer			5000	02/01/2023	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the DXPE Form 144 disclose?

The filing discloses a proposed sale of 5,000 common shares with an aggregate market value of $589,800, to be executed via Charles Schwab on 08/12/2025.

When and how were the DXPE shares being sold acquired?

The shares were acquired on 02/01/2023 as restricted stock issuances from the issuer, and the purchase/payment date is listed as 02/01/2023.

Has the filer sold other DXPE securities recently?

The Form 144 states Nothing to Report under securities sold during the past three months for the account.

Where will the DXPE shares be sold and through which broker?

The filing names Charles Schwab & Co (address shown) as the broker and lists the Nasdaq as the exchange.

Does the filer claim to have any undisclosed material information about DXPE?

By signing the notice the filer represents they do not know any material adverse information